溶解性 | DMSO <20mg/mL; Ethanol <20mg/mL; DMF <20mg/mL |
存贮条件 | 储存温度-20°C |
产品介绍 | Salirasib是一种有效的竞争性prenylated protein methyltransferase (PPMTase)抑制剂, Ki为2.6 μM,其抑制Ras甲基化。Phase 2。 |
生化机理 | Salirasib is a salicylic acid derivative with potential antineoplastic activity. Salirasib dislodges all Ras isoforms from their membrane-anchoring sites, thereby preventing activation of RAS signaling cascades that mediated cell proliferation, differentiation, and senescence. RAS signaling is believed to be abnormally activated in one-third of human cancers, including cancers of the pancreas, colon, lung and breast. Salirasib binds to a cell membrane anchor protein thereby selectively blocking a cascade of biochemical signals known as the Ras signaling pathway. The Ras pathway plays an important role in tumor growth and is believed to be abnormally activated in one-third of human cancers, including cancers of the pancreas, colon, lung and breast. Up to 90% of human pancreatic cancers are driven by aberrant oncogenic Ras signaling. |
别名 | ;S-Farnesylthiosalicylic acid; Farnesyl Thiosalicylic Acid; FTS |
Salirasib,竞争性PPMTase抑制剂
Salirasib (订货以英文为准)
编号:S124985
CAS号:162520-00-5
分子式:C22H30O2S
分子量:358.54
产品名称 | Salirasib |
中文名称 | Salirasib,竞争性PPMTase抑制剂 |
CAS号 | 162520-00-5 |
分子式(M.F.) | C22H30O2S |
分子量(M.W.) | 358.54 |
储存条件 | -20°C储存 |
搜索质检报告(COA)
搜索MSDS
相关产品